UCL Cancer Institute


Welcome to UCL Cancer Institute 

The UCL Cancer Institute is the hub for cancer research at University College London, one of the World's leading universities. The Institute draws together over 300 talented scientists who are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. If you are thinking about studying with us, applications to our flagship MSc Cancer programme are open until 28 July for September 2017 entry, plus a new and unique undergraduate degree BSc Cancer Biomedicine starting 2018.

News and features

FOXFIRE combined analysis study results announced

Analysis from the FOXFIRE studies, led by Professor Ricky Sharma, indicates no benefit in overall survival from adding selective internal radiotherapy [SIRT] to first-line oxaliplatin-based chemotherapy for metastatic colorectal cancer.

Published: May 23, 2017 4:36:15 PM

Drug improves survival of patients with rare cancer by almost a quarter

Patients who take the chemotherapy drug, capecitabine, after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug, according to the results of a phase III clinical trial presented at the 2017 ASCO Annual Meeting in Chicago.

Published: May 23, 2017 4:36:15 PM

Tracking unstable chromosomes helps predict lung cancer’s return

Scientists at UCL, UCLH and the Francis Crick Institute have found that unstable chromosomes within lung tumours increase the risk of cancer returning after surgery, and have used this new knowledge to detect relapse long before standard testing.

Published: Apr 27, 2017 5:55:03 PM

International team receive $1.2 million boost for neuroendocrine cancer research

A scientific collaboration between UCL, Dana-Farber Cancer Institute, UCSF Medical Centre and the UCL Cancer Institute / Royal Free Hospital London has been awarded a $1.2m accelerator grant from the Neuroendocrine Tumor Research Foundation (NETRF) to help advance research into small intestine neuroendocrine tumours (SI-NETs).

Published: Apr 27, 2017 4:16:14 PM

Cancer Research UK-UCL Centre

Cancer Research UK-UCL Centre

The Cancer Research UK-UCL Centre is a network and partnership between Cancer Research UK, UCL and UCL's associated Hospital Trusts. The Centre's mission is to facilitate collaboration to advance world-class translational cancer research.

Study with us

Study with us

Our education programmes reflect the depth and breadth of research expertise within the UCL Cancer Institute. Join our community of research scientists and academic clinicians through our postgraduate taught MSc Cancer or PhD studies.

Clinical Trials

Clinical Trials

The Cancer Research UK and UCL Cancer Trials Centre is one of the largest cancer trials centres in the UK. The CTC conducts multi-centre national and international phase III trials, feasibility studies and early phase I and II studies.

Our Research

Our Research

UCL is a world leader in interdisciplinary research. The UCL Cancer Institute is uniquely placed to leverage this multidisciplinary approach to advance discoveries in basic, translational and clinical cancer research.


UCL Special Grand Round

UCL School of Life and Medical Sciences presents: Imaging-guided diagnosis and therapy.

Starts: Jun 7, 2017 12:30:00 PM

Support our work

GCLP lab

Help us to continue the research that will lead to the breakthroughs in therapies for cancer patients. Support us >

Action for equality and diversity 

Athena SWAN Silver Award

UCL Cancer Institute holds an Athena SWAN silver award in recognition of it's commitment to advancing equality, diversity and careers. 

Learn more about Athena SWAN initiatives >

Connect with us